Outcome of FDA stem cell meeting likely to please no one
It’s been a big 2 weeks in terms of media interest in talking about the upcoming FDA meeting on stem cell oversight taking place in just a few weeks. There are many questions about this meeting and I’m planning to tackle some of the questions in upcoming posts including next week. These questions include, “who […]
Outcome of FDA stem cell meeting likely to please no one Read More »